Skip to main content
NCBI home page
Gut logoLink to Gut
. 1996 Jan;38(1):129–134. doi: 10.1136/gut.38.1.129

Assessment of variceal pressure by continuous non-invasive endoscopic registration: a placebo controlled evaluation of the effect of terlipressin and octreotide.

F Nevens 1, W Van Steenbergen 1, S H Yap 1, J Fevery 1
PMCID: PMC1382991  PMID: 8566840

Abstract

Octreotide has been proposed for the treatment of variceal bleeding. The effects on portal pressure, however, have been variable in published studies. As bleeding is more directly related to pressure in the varices, this study investigated the effect on variceal pressure of octreotide and terlipressin, a vasoactive drug with a well established effect. Variceal pressure was measured during four to eight minutes by a continuous non-invasive endoscopic registration method. Thirty patients in whom a stable variceal pressure recording had been obtained during at least one minute, were randomised to receive either 2 mg terlipressin, 50 micrograms octreotide or an identical volume of saline, as a single intravenous injection given over 60 seconds. For the final analysis three patients had to be excluded because of lack of a satisfactory recording. There were no significant clinical differences between the three groups of patients. Placebo administration did not induce significant changes, but a mean decrease in variceal pressure of -27% was noted with terlipressin, starting from two minutes onwards. Variceal pressure changes after injection of octreotide were variable and the mean change in pressure did not reach statistical significance. Seven of 10 patients showed a temporary increase in variceal pressure. In conclusion, terlipressin induces a significant and progressive decrease in variceal pressure but inconsistent variations of variceal pressure changes were seen after octreotide administration. This is probably related to its effect on central venous pressure. This study also shows that continuous variceal pressure recording with the non-invasive endoscopic registration technique detects in an accurate way the effect of vasoactive drugs on variceal pressure, because placebo injection did not produce significant changes.

Full text

PDF
129

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bosch J., Bordas J. M., Rigau J., Viola C., Mastai R., Kravetz D., Navasa M., Rodés J. Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy. Hepatology. 1986 Jul-Aug;6(4):667–672. doi: 10.1002/hep.1840060421. [DOI] [PubMed] [Google Scholar]
  2. Cestari R., Braga M., Missale G., Ravelli P., Burroughs A. K. Haemodynamic effect of triglycyl-lysine-vasopressin (glypressin) on intravascular oesophageal variceal pressure in patients with cirrhosis. A randomized placebo controlled trial. J Hepatol. 1990 Mar;10(2):205–210. doi: 10.1016/0168-8278(90)90053-t. [DOI] [PubMed] [Google Scholar]
  3. Eriksson L. S., Brundin T., Söderlund C., Wahren J. Haemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis. Scand J Gastroenterol. 1987 Oct;22(8):919–925. doi: 10.3109/00365528708991936. [DOI] [PubMed] [Google Scholar]
  4. Feu F., Bordas J. M., Garcia-Pagán J. C., Bosch J., Rodés J. Double-blind investigation of the effects of propranolol and placebo on the pressure of esophageal varices in patients with portal hypertension. Hepatology. 1991 May;13(5):917–922. [PubMed] [Google Scholar]
  5. Feu F., Bordas J. M., Luca A., García-Pagán J. C., Escorsell A., Bosch J., Rodés J. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis. Hepatology. 1993 Nov;18(5):1082–1089. [PubMed] [Google Scholar]
  6. Freeman J. G., Cobden I., Record C. O. Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding. J Clin Gastroenterol. 1989 Feb;11(1):58–60. doi: 10.1097/00004836-198902000-00014. [DOI] [PubMed] [Google Scholar]
  7. Garcia-Tsao G., Groszmann R. J., Fisher R. L., Conn H. O., Atterbury C. E., Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology. 1985 May-Jun;5(3):419–424. doi: 10.1002/hep.1840050313. [DOI] [PubMed] [Google Scholar]
  8. Hosking S. W., Robinson P., Johnson A. G. Effect of Valsalva's manoeuvre and hyoscinbutylbromide on the pressure gradient across the wall of oesophageal varices. Gut. 1987 Sep;28(9):1151–1156. doi: 10.1136/gut.28.9.1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hwang S. J., Lin H. C., Chang C. F., Lee F. Y., Lu C. W., Hsia H. C., Wang S. S., Lee S. D., Tsai Y. T., Lo K. J. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. J Hepatol. 1992 Nov;16(3):320–325. doi: 10.1016/s0168-8278(05)80663-4. [DOI] [PubMed] [Google Scholar]
  10. Kleber G., Sauerbruch T., Fischer G., Paumgartner G. Somatostatin does not reduce oesophageal variceal pressure in liver cirrhotics. Gut. 1988 Feb;29(2):153–156. doi: 10.1136/gut.29.2.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lin H. C., Tsai Y. T., Lee F. Y., Lee S. D., Hsia H. C., Lin W. J., Lo K. J. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Gastroenterology. 1992 Jul;103(1):229–234. doi: 10.1016/0016-5085(92)91117-m. [DOI] [PubMed] [Google Scholar]
  12. McKee R. A study of octreotide in oesophageal varices. Digestion. 1990;45 (Suppl 1):60–65. doi: 10.1159/000200264. [DOI] [PubMed] [Google Scholar]
  13. Mosimann R. Nonaggressive assessment of portal hypertension using endoscopic measurement of variceal pressure. Preliminary report. Am J Surg. 1982 Feb;143(2):212–214. doi: 10.1016/0002-9610(82)90070-8. [DOI] [PubMed] [Google Scholar]
  14. Nevens F., Sprengers D., Fevery J. The effect of different doses of a bolus injection of somatostatin combined with a slow infusion on transmural oesophageal variceal pressure in patients with cirrhosis. J Hepatol. 1994 Jan;20(1):27–31. doi: 10.1016/s0168-8278(05)80463-5. [DOI] [PubMed] [Google Scholar]
  15. Rigau J., Bosch J., Bordas J. M., Navasa M., Mastai R., Kravetz D., Bruix J., Feu F., Rodés J. Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage. Gastroenterology. 1989 Mar;96(3):873–880. [PubMed] [Google Scholar]
  16. Silvain C., Carpentier S., Sautereau D., Czernichow B., Métreau J. M., Fort E., Ingrand P., Boyer J., Pillegand B., Doffël M. Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial. Hepatology. 1993 Jul;18(1):61–65. [PubMed] [Google Scholar]
  17. Staritz M., Poralla T., Meyer zum Büschenfelde K. H. Intravascular oesophageal variceal pressure (IOVP) assessed by endoscopic fine needle puncture under basal conditions, Valsalva's manoeuvre and after glyceryltrinitrate application. Gut. 1985 May;26(5):525–530. doi: 10.1136/gut.26.5.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sung J. J., Chung S. C., Lai C. W., Chan F. K., Leung J. W., Yung M. Y., Kassianides C., Li A. K. Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet. 1993 Sep 11;342(8872):637–641. doi: 10.1016/0140-6736(93)91758-e. [DOI] [PubMed] [Google Scholar]
  19. Söderlund C., Magnusson I., Törngren S., Lundell L. Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol. 1990 Jun;25(6):622–630. doi: 10.3109/00365529009095539. [DOI] [PubMed] [Google Scholar]
  20. Walker S., Stiehl A., Raedsch R., Kommerell B. Terlipressin in bleeding esophageal varices: a placebo-controlled, double-blind study. Hepatology. 1986 Jan-Feb;6(1):112–115. doi: 10.1002/hep.1840060121. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES